Page results
-
Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
UCLH will play a vital role in a new respiratory virus study.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
UCLH has declared a climate and health emergency, and has published a 10-point climate action plan to reach net zero carbon dioxide emissions by 2031.
-
The diabetes team have revisited their tips for managing diabetes over the Christmas holidays and updated them for 2022.
-
Information about our UCLH Charity, charity funds and associated charities.
-
Our staff have rated UCLH as the top trust in England, improving on our ranking from last year when we were third best in England and top in London.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
File results
-
FOI/2024/0495 - Voice, data and network - LAN, WLAN, data centre, WAN/ internet connectivity, SIP, telephony, teams phone system, contact centre
-
FOI/2024/0496 - Outpatient procedures for 2023/24
-
FOI/2024/0502 - GP/A&E appointments/ deaths from overdose of weight loss drugs Saxenda/ ozempic/ wegovy
-
FOI/2024/0503 - Frozen food preparation methods
-
FOI/2024/0506 - Permanent/ fixed-term/ international recruitment
-
FOI/2024/0509 - Structure chart for Estates and Facilities
-
FOI/2024/0511 - Radiotherapy treatment planning system/artificial intelligence (AI)/ costs
-
FOI/2024/0512 - Patient harm and the cost 2020-2023
-
FOI/2024/0513 - Robotic platforms for surgery costs/ contract
-
FOI/2024/0514 - Viscosupplementation injections/ spend